John Cleveland is ready to pay a lot more for his health insurance next year. He hasn’t forgotten the pile of hospital bills that awaited him after he had a seizure while tending to customers in his Austin, Texas, barbershop four years ago. Once doctors hurriedly removed the dangerous tumor growing on his brain, a…
As the government shutdown continues over debates on whether or not to extend the Marketplace enhanced tax credits, this KFF Health Tracking poll finds that three quarter of the public continues to say Congress should extend the tax credits, while partisan loyalties among the public are deepening on the issue.
As the government shutdown continues, public support remains high for extending the enhanced ACA tax credits set to expire at the end of the year, with three quarters (74%) of the public in favor of extending them, a new KFF Health Tracking Poll finds.
That is the question a new paper by Chambers et al. (2025) aims to answer. The authors use data from the Specialty Drug Evidence and Coverage (SPEC) Database, which contains coverage policies related to specialty pharmacy for a large number of US health plans, to examine how n=25 cell and gene therapies are being covered…
AI continues to dominate digital health funding, but investors and health systems are demanding proof that these tools actually save money — and quickly. AI startups without clear, measurable ROI are finding it harder to stand out, explained Vig Chandramouli, partner at Oak HC/FT. The post Why ‘Time-to-Value’ Is the #1 Metric Healthcare AI Customers…
Financial and policy trends are shifting the M&A landscape now, says a Kaufman Hall expert
UnitedHealthcare has partnered with Aeroflow Health to provide virtual, dietitian-led nutrition services for members managing chronic conditions. The post UHC Taps Aeroflow Health for Virtual Nutrition Services appeared first on MedCity News.
Increasing costs are driven by chronic diseases, pharmacy expenses, and labor shortages
Collaborative for Healthy Rural America includes Lumeris, Teladoc Health, Nuna, Deloitte, and Unite Us
The FDA has approved UCB’s Kygevvi for treating children and adults with thymidine kinase 2 deficiency, an inherited mitochondrial disorder. It’s the drugmaker’s first ultra-rare disease product. The post UCB Drug Becomes First FDA-Approved Treatment for Ultra-Rare and Fatal Mitochondrial Disease appeared first on MedCity News.